EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Novel Microfluidic System for 3D Epidermis and Full‐Thickness Skin Growth for Nanoparticle Safety Assessment

Samantha Costa iD, Ana B Carneiro, Filipa Lebre iD, João Meneses iD, Alar Ainla iD, Cacilda Moura iD, Ernesto Alfaro-Moreno iD, Ana R Ribeiro iD

Advanced Healthcare Materials · 2026

DOI: 10.1002/adhm.202502518 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Samantha Costa und 7 weiteren Autor:innen. Beteiligte Einrichtung: BiotechHealth PhD Candidate, Institute for Biomedical Sciences Abel Salazar of the University of Porto (ICBAS-UP), Porto, 4050-313, Portugal. Hauptthemen laut MEDLINE: Epidermis, Nanoparticles, Lab-On-A-Chip Devices, Skin. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: LEARN Project (Horizon Europe), SbDToolBox Project (Norte 2020), FCT - Fundação para a Ciência e Tecnologia, I.P. by project reference 2023.04124.BDANA and DOI : https://doi.org/10.54499/2023.04124.BDANA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic skin exposure to nanoparticles (NPs) from air pollution, cosmetics, tattoo inks, and smart textiles is linked to adverse effects such as accelerated aging, dermatitis, eczema, and increased melanoma risk. However, the limited predictive power and physiological relevance of conventional in vitro models, combined with the absence of standardized protocols for assessing NP toxicity, remain a major challenge. To address these limitations, the development of skin‐on‐chip (SoC) systems provides a more physiologically relevant solution, surpassing the constraints of static skin cultures. Here, a novel SoC model with dynamic perfusion and a modular architecture suitable for epidermis‐only (EoC) and full‐thickness (FT) skin models isdeveloped. Under dynamic conditions, both models are metabolically active, exhibit enhanced barrier function, and display a morphology resembling native human skin. Exposure to titanium dioxide (TiO 2 ) NPs led to a 32.4% decrease in barrier integrity, a 12.1% reduction in metabolic activity, a 2.9% increase in permeability, and histological evidence of tissue damage. These alterations are associated with an early moderate inflammatory response, as indicated by the upregulation of chemokines. Collectively, these findings demonstrate that the microfluidic device functions as a versatile toxicological tool, with the biological complexity of the FT SoC enhancing its sensitivity for nanotoxicology studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpidermisNanoparticlesLab-On-A-Chip DevicesSkinMicrofluidicsHumansTitaniumAnimalsKeratinocytes

Stichwörter der Autor:innen

microfluidicsnanotechnologynanotoxicologyskin‐on‐chiptitanium dioxide nanoparticles

Substanzen

Titaniumtitanium dioxide

Autor:innen und Institutionen

  • BiotechHealth PhD Candidate, Institute for Biomedical Sciences Abel Salazar of the University of Porto (ICBAS-UP), Porto, 4050-313, Portugal.
  • Master in Biophysics and Bionanosystems, School of Sciences of the University of Minho (ECUM), Braga, 4710-057, Portugal.
  • International Iberian Nanotechnology Laboratory (INL), Braga, 4715-330, Portugal.
  • Department of Bioengineering Technologies, Faculty of Science and Technology, TechMedCentre, University of Twente, Enschede, 7522 NB, The Netherlands.
  • Physics Center of Minho and Porto Universities (CF-UM-UP), Braga, 4710-057, Portugal.

ORCID-Profile: Samantha Costa, Filipa Lebre, João Meneses, Alar Ainla, Cacilda Moura, Ernesto Alfaro-Moreno, Ana R Ribeiro

Förderung

  • LEARN Project (Horizon Europe)
  • SbDToolBox Project (Norte 2020)
  • FCT - Fundação para a Ciência e Tecnologia, I.P. by project reference 2023.04124.BDANA and DOI : https://doi.org/10.54499/2023.04124.BDANA
  • Sinfonia Project (Horizon 2020)

Zitieren

APA

Costa, S., Carneiro, A. B., Lebre, F., Meneses, J., Ainla, A., Moura, C., Alfaro-Moreno, E., & Ribeiro, A. R. (2026). A Novel Microfluidic System for 3D Epidermis and Full‐Thickness Skin Growth for Nanoparticle Safety Assessment. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202502518

Vancouver

Costa S, Carneiro AB, Lebre F, Meneses J, Ainla A, Moura C, et al. A Novel Microfluidic System for 3D Epidermis and Full‐Thickness Skin Growth for Nanoparticle Safety Assessment. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202502518

BibTeX
@article{Costa2026,
  author = {Costa, Samantha and Carneiro, Ana B and Lebre, Filipa and Meneses, João and Ainla, Alar and Moura, Cacilda and Alfaro-Moreno, Ernesto and Ribeiro, Ana R},
  title = {A Novel Microfluidic System for 3D Epidermis and Full‐Thickness Skin Growth for Nanoparticle Safety Assessment},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  doi = {10.1002/adhm.202502518}
}
Kostenlos starten →